| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| J3KN20 | CREB/ATF bZIP transcription factor; Fragment; | CREBZF; | NULL | 284 | human |
| A0A059QR28 | Cytochrome b; | CYTB; | NULL | 380 | human |
| A1L305 | DLEC1 protein; | DLEC1; | NULL | 711 | human |
| B2KMS3 | NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3; | ND5; | NULL | 603 | human |
| A6NE76 | Cullin-4B; Fragment; | CUL4B; | NULL | 234 | human |
| B3KT91 | POU domain protein; | NULL | NULL | 301 | human |
| A0A060VD03 | MHC class I antigen; | HLA-C; | NULL | 366 | human |
| Q14V85 | Truncated cytochrome P450, family 3, subfamily A, polypeptide 5; | CYP3A5; | NULL | 347 | human |
| B3IU76 | Interleukin 5 receptor alpha transcript variant 7; | IL5RA; | NULL | 325 | human |
| B3KVD5 | cDNA FLJ16430 fis, clone BRACE3009044, highly similar to Centaurin-gamma 1; | NULL | NULL | 848 | human |
| B2R6M6 | cDNA, FLJ93024, highly similar to Homo sapiens EGF-containing fibulin-like extracellular matrix protein 1 (EFEMP1), transcript variant 1, mRNA; | NULL | NP_001034437.1; | 493 | human |
| B4DZS8 | Peptidyl-prolyl cis-trans isomerase; Fragment; | NULL | NULL | 877 | human |
| B4DMA1 | cDNA FLJ61316; | NULL | XP_006718530.1; | 697 | human |
| B4E200 | cDNA FLJ57929, moderately similar to Peptidyl-prolyl cis-trans isomerase C; EC5.2.1.8; | NULL | NULL | 132 | human |
| B4E0Q3 | cDNA FLJ51432, highly similar to Dynamin-binding protein; | NULL | NULL | 513 | human |
| A8K228 | cDNA FLJ77874, highly similar to Homo sapiens glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase), mRNA; | NULL | NP_055106.1; | 419 | human |
| B2LYR2 | CD247 transcript variant 2; Fragment; | CD247; | NULL | 100 | human |
| B4DM85 | cDNA FLJ56002, highly similar to Kinesin-like protein KIF2; | NULL | NULL | 744 | human |
| B3KUL8 | cDNA FLJ40195 fis, clone TESTI2019787, highly similar to T-box transcription factor TBX22; | NULL | NP_001103348.1;NP_001103349.1; | 400 | human |
| B7Z5Y1 | cDNA FLJ54143, highly similar to Neuroligin-3; | NULL | NULL | 266 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |